Editing BCG vaccine (section)

=== Type 1 diabetes ===
{{As of|2017}}, BCG vaccine is in the early stages of being studied in [[type 1 diabetes]] (T1D).<ref>{{cite journal | vauthors = Kühtreiber WM, Tran L, Kim T, Dybala M, Nguyen B, Plager S, Huang D, Janes S, Defusco A, Baum D, Zheng H, Faustman DL | title = Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations | journal = npj Vaccines | volume = 3 | pages = 23 | year = 2018 | pmid = 29951281 | pmc = 6013479 | doi = 10.1038/s41541-018-0062-8 }}</ref><ref>{{cite journal | vauthors = Kowalewicz-Kulbat M, Locht C | title = BCG and protection against inflammatory and auto-immune diseases | journal = Expert Review of Vaccines | volume = 16 | issue = 7 | pages = 699–708 | date = July 2017 | pmid = 28532186 | doi = 10.1080/14760584.2017.1333906 | s2cid = 4723444 }}</ref>